SonarMD continues to gain momentum in 2021 as the leading valuebased care coordination solution for complex chronic diseases, highlighted by record-setting patient
engagement rates in its newest market and updated chief executive leadership.
Today the company announces the successful launch of a value-based agreement with a major insurer in
Minnesota and Minneapolis-based MNGI Digestive Health. In the first three weeks of the collaboration,
SonarMD engaged 75% of eligible MNGI patients with Inflammatory Bowel Diseases (Crohn’s and
ulcerative colitis) in its longitudinal remote monitoring program, which is proven to reduce the need for
ER visits and hospitalizations, lowering costs by 15% per patient per year.